Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
CCLD vs PHR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
CCLD vs PHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services |
| Market Cap | $1.13B | $575M |
| Revenue (TTM) | $120M | $463M |
| Net Income (TTM) | $11M | $-5M |
| Gross Margin | 34.1% | 68.2% |
| Operating Margin | 9.5% | -1.9% |
| Forward P/E | 17.1x | 29.6x |
| Total Debt | $4M | $18M |
| Cash & Equiv. | $3M | $84M |
CCLD vs PHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CareCloud, Inc. (CCLD) | 100 | 45.6 | -54.4% |
| Phreesia, Inc. (PHR) | 100 | 32.5 | -67.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCLD vs PHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCLD carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 199.0% 10Y total return vs PHR's -62.0%
- Lower P/E (17.1x vs 29.6x)
- 9.0% margin vs PHR's -1.2%
PHR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.79
- Rev growth 17.8%, EPS growth 59.4%, 3Y rev CAGR 25.3%
- Lower volatility, beta 0.79, Low D/E 6.7%, current ratio 1.78x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.8% revenue growth vs CCLD's 8.7% | |
| Value | Lower P/E (17.1x vs 29.6x) | |
| Quality / Margins | 9.0% margin vs PHR's -1.2% | |
| Stability / Safety | Beta 0.79 vs CCLD's 1.15, lower leverage | |
| Dividends | 0.6% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +39.7% vs PHR's -60.7% | |
| Efficiency (ROA) | 13.2% ROA vs PHR's -1.3%, ROIC 15.9% vs -23.3% |
CCLD vs PHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CCLD vs PHR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CCLD leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHR is the larger business by revenue, generating $463M annually — 3.8x CCLD's $120M. CCLD is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to PHR's -1.2%. On growth, CCLD holds the edge at +21.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $120M | $463M |
| EBITDAEarnings before interest/tax | $28M | $20M |
| Net IncomeAfter-tax profit | $11M | -$5M |
| Free Cash FlowCash after capex | $29M | $42M |
| Gross MarginGross profit ÷ Revenue | +34.1% | +68.2% |
| Operating MarginEBIT ÷ Revenue | +9.5% | -1.9% |
| Net MarginNet income ÷ Revenue | +9.0% | -1.2% |
| FCF MarginFCF ÷ Revenue | +23.7% | +9.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.9% | +12.7% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -88.3% |
Valuation Metrics
PHR leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.1B | $575M |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $508M |
| Trailing P/EPrice ÷ TTM EPS | 29.90x | -9.34x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.09x | 29.63x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 40.25x | — |
| Price / SalesMarket cap ÷ Revenue | 9.42x | 1.37x |
| Price / BookPrice ÷ Book value/share | 19.07x | 2.07x |
| Price / FCFMarket cap ÷ FCF | 39.73x | 69.29x |
Profitability & Efficiency
CCLD leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CCLD delivers a 19.0% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-2 for PHR. PHR carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCLD's 0.07x. On the Piotroski fundamental quality scale (0–9), PHR scores 6/9 vs CCLD's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.0% | -1.7% |
| ROA (TTM)Return on assets | +13.2% | -1.3% |
| ROICReturn on invested capital | +15.9% | -23.3% |
| ROCEReturn on capital employed | +20.0% | -21.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.07x | 0.07x |
| Net DebtTotal debt minus cash | $1M | -$66M |
| Cash & Equiv.Liquid assets | $3M | $84M |
| Total DebtShort + long-term debt | $4M | $18M |
| Interest CoverageEBIT ÷ Interest expense | 40.06x | -1.01x |
Total Returns (Dividends Reinvested)
CCLD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCLD five years ago would be worth $3,756 today (with dividends reinvested), compared to $1,984 for PHR. Over the past 12 months, CCLD leads with a +39.7% total return vs PHR's -60.7%. The 3-year compound annual growth rate (CAGR) favors CCLD at -0.2% vs PHR's -31.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +2.7% | -41.5% |
| 1-Year ReturnPast 12 months | +39.7% | -60.7% |
| 3-Year ReturnCumulative with dividends | -0.7% | -67.9% |
| 5-Year ReturnCumulative with dividends | -62.4% | -80.2% |
| 10-Year ReturnCumulative with dividends | +199.0% | -62.0% |
| CAGR (3Y)Annualised 3-year return | -0.2% | -31.5% |
Risk & Volatility
Evenly matched — CCLD and PHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
PHR is the less volatile stock with a 0.79 beta — it tends to amplify market swings less than CCLD's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CCLD currently trades 74.6% from its 52-week high vs PHR's 29.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 0.79x |
| 52-Week HighHighest price in past year | $4.01 | $32.76 |
| 52-Week LowLowest price in past year | $1.80 | $7.77 |
| % of 52W HighCurrent price vs 52-week peak | +74.6% | +29.1% |
| RSI (14)Momentum oscillator 0–100 | 44.7 | 50.1 |
| Avg Volume (50D)Average daily shares traded | 548K | 1.9M |
Analyst Outlook
PHR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CCLD as "Buy" and PHR as "Buy". Consensus price targets imply 181.8% upside for PHR (target: $27) vs 8.7% for CCLD (target: $3). CCLD is the only dividend payer here at 0.55% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.25 | $26.86 |
| # AnalystsCovering analysts | 7 | 25 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CCLD leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PHR leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
CCLD vs PHR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CCLD or PHR a better buy right now?
For growth investors, Phreesia, Inc.
(PHR) is the stronger pick with 17. 8% revenue growth year-over-year, versus 8. 7% for CareCloud, Inc. (CCLD). CareCloud, Inc. (CCLD) offers the better valuation at 29. 9x trailing P/E (17. 1x forward), making it the more compelling value choice. Analysts rate CareCloud, Inc. (CCLD) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCLD or PHR?
On forward P/E, CareCloud, Inc.
is actually cheaper at 17. 1x.
03Which is the better long-term investment — CCLD or PHR?
Over the past 5 years, CareCloud, Inc.
(CCLD) delivered a total return of -62. 4%, compared to -80. 2% for Phreesia, Inc. (PHR). Over 10 years, the gap is even starker: CCLD returned +199. 0% versus PHR's -62. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCLD or PHR?
By beta (market sensitivity over 5 years), Phreesia, Inc.
(PHR) is the lower-risk stock at 0. 79β versus CareCloud, Inc. 's 1. 15β — meaning CCLD is approximately 44% more volatile than PHR relative to the S&P 500. On balance sheet safety, Phreesia, Inc. (PHR) carries a lower debt/equity ratio of 7% versus 7% for CareCloud, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CCLD or PHR?
By revenue growth (latest reported year), Phreesia, Inc.
(PHR) is pulling ahead at 17. 8% versus 8. 7% for CareCloud, Inc. (CCLD). On earnings-per-share growth, the picture is similar: CareCloud, Inc. grew EPS 135. 7% year-over-year, compared to 59. 4% for Phreesia, Inc.. Over a 3-year CAGR, PHR leads at 25. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCLD or PHR?
CareCloud, Inc.
(CCLD) is the more profitable company, earning 9. 0% net margin versus -13. 9% for Phreesia, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCLD leads at 9. 5% versus -13. 8% for PHR. At the gross margin level — before operating expenses — PHR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCLD or PHR more undervalued right now?
On forward earnings alone, CareCloud, Inc.
(CCLD) trades at 17. 1x forward P/E versus 29. 6x for Phreesia, Inc. — 12. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PHR: 181. 8% to $26. 86.
08Which pays a better dividend — CCLD or PHR?
In this comparison, CCLD (0.
6% yield) pays a dividend. PHR does not pay a meaningful dividend and should not be held primarily for income.
09Is CCLD or PHR better for a retirement portfolio?
For long-horizon retirement investors, CareCloud, Inc.
(CCLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 0. 6% yield, +199. 0% 10Y return). Both have compounded well over 10 years (CCLD: +199. 0%, PHR: -62. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCLD and PHR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CCLD is a small-cap quality compounder stock; PHR is a small-cap high-growth stock. CCLD pays a dividend while PHR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.